High-Dollar, High-Risk: Managing the Revenue Cycle in Oncology and Hematology

Jul 10, 2026 by in Uncategorized Comments Off on High-Dollar, High-Risk: Managing the Revenue Cycle in Oncology and Hematology

No specialty carries more financial exposure per claim than oncology. A single infusion encounter can represent tens of thousands of dollars in drug costs alone — which means a single…

read more